Matthew Davidson
ADIAL PHARMACEUTICALS, INC.
Matthew Davidson is the CEO of ADIAL PHARMACEUTICALS, INC. (ADIL).
Latest on The Wire
See all →Adial Pharmaceuticals plans leadership changes tied to annual meeting vote
Aug 13 · via Investing.comAdial Pharmaceuticals Plans Major Leadership and Board Transition
Aug 13 · via TipRanksAdial closes $32 million financing, grants stock to new executives
Jun 16 · via Investing.comAdial Pharmaceuticals Expands Executive Leadership Team and Closes PIPE Financing
Jun 16 · via GlobeNewswire
Recent developments
AI summary of recent coverageRecent coverage has focused on Adial Pharmaceuticals undergoing significant executive and board transitions, with planned leadership changes tied to an upcoming annual meeting vote. The company has also secured $32 million in financing and granted stock to newly appointed executives as part of an expansion of its leadership team.
Summarized from the headlines below; see each source for the full story.
Our coverage
On CEOInsider
No feature yet. When we publish a feature, interview or cover story on Matthew Davidson, it will appear here — and tie into the news timeline.
4 stories tracked
In the News
- Investing.com·
Adial Pharmaceuticals plans leadership changes tied to annual meeting vote
- TipRanks·
Adial Pharmaceuticals Plans Major Leadership and Board Transition
- Investing.com·
Adial closes $32 million financing, grants stock to new executives
- GlobeNewswire·
Adial Pharmaceuticals Expands Executive Leadership Team and Closes PIPE Financing
Matthew Davidson: FAQ
- What company does Matthew Davidson lead?
- Matthew Davidson is CEO of ADIAL PHARMACEUTICALS, INC..